Trial Profile
Comparative lung bioactivity of HFA-Seretide via spacer devices in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2008
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 08 Sep 2006 New trial record.